Literature DB >> 33622489

Severe Pulmonary Disease Caused by Mycolicibacter kumamotonensis.

Katerina Manika, Fanourios Kontos, Apostolos Papavasileiou, Dimitrios Papaventsis, Maria Sionidou, Ioannis Kioumis.   

Abstract

Severe Mycolicibacter kumamotonensis-pulmonary disease was diagnosed in a 68-year-old immunocompetent woman in Greece; the disease was initially treated as tuberculosis. The patient responded favorably to a new treatment regimen of azithromycin, amikacin, moxifloxacin, and linezolid. Complete symptom resolution and radiologic improvement resulted.

Entities:  

Keywords:  Greece; Mycolicibacter kumamotonensis; bacteria; nontuberculous mycobacteria; pulmonary disease; respiratory infections; tuberculosis and other mycobacteria

Mesh：

Substances：

Year:  2021        PMID： 33622489      PMCID： PMC7920653          DOI： 10.3201/eid2703.191648

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  9 in total

1.  Mycobacterium kumamotonense Sp. Nov. recovered from clinical specimen and the first isolation report of Mycobacterium arupense in Japan: Novel slowly growing, nonchromogenic clinical isolates related to Mycobacterium terrae complex.

Authors:  Takayuki Masaki; Kiyofumi Ohkusu; Hiroyuki Hata; Nagatoshi Fujiwara; Hirotoshi Iihara; Makiko Yamada-Noda; Pham Hong Nhung; Masahiro Hayashi; Yuko Asano; Yoshiaki Kawamura; Takayuki Ezaki
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Survey of 150 strains belonging to the Mycobacterium terrae complex and description of Mycobacterium engbaekii sp. nov., Mycobacterium heraklionense sp. nov. and Mycobacterium longobardum sp. nov.

Authors:  Enrico Tortoli; Zoe Gitti; Hans-Peter Klenk; Stefania Lauria; Roberta Mannino; Paola Mantegani; Alessandro Mariottini; Ioannis Neonakis
Journal:  Int J Syst Evol Microbiol       Date:  2012-03-23       Impact factor: 2.747

4.  Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera.

Authors:  Radhey S Gupta; Brian Lo; Jeen Son
Journal:  Front Microbiol       Date:  2018-02-13       Impact factor: 5.640

5.  Prevalence and molecular characterization of non-tuberculous mycobacteria in hospital soil and dust of a developing country, Iran.

Authors:  Masoumeh Davarpanah; Davood Azadi; Hasan Shojaei
Journal:  Microbiology       Date:  2019-12       Impact factor: 2.777

6.  Isolation of Mycobacterium kumamotonense from a patient with pulmonary infection and latent tuberculosis.

Authors:  Fanourios Kontos; Dimitrios Nikitas Mavromanolakis; Marina Chari Zande; Zoe Georgios Gitti
Journal:  Indian J Med Microbiol       Date:  2016 Apr-Jun       Impact factor: 0.985

7.  Soft tissue infection caused by Mycolicibacter kumamotonensis.

Authors:  Maho Iemura-Kashiwagi; Isao Ito; Ryosuke Ikeguchi; Masatoshi Kadoya; Tomoki Iemura; Shiomi Yoshida; Katsuhiro Suzuki; Toyohiro Hirai
Journal:  J Infect Chemother       Date:  2019-07-23       Impact factor: 2.211

Review 8.  Mycobacterium terrae: case reports, literature review, and in vitro antibiotic susceptibility testing.

Authors:  D S Smith; P Lindholm-Levy; G A Huitt; L B Heifets; J L Cook
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

9.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.